Public Health & Policy
FDA General
- By the Numbers
- Clinical Trials
- Environmental Health
- Equity in Medicine
- Ethics
- FDA General
- General Professional Issues
- Health Policy
- Medicaid
- Medical Education
- Medicare
- Military Medicine
- Opioids
- Practice Management
- Product Alert
- Public Health
- Repeal and Replace
- Stem Cell Research
- Washington Watch
- Work Force
More in FDA General
Zolbetuximab indicated alongside fluoropyrimidine- and platinum-containing chemotherapy
Oct 18, 2024
In confirmatory trial, antibody-drug conjugate failed to improve OS versus chemotherapy
Oct 18, 2024
Lawsuit aims to require three in-person doctor visits, bar drug's use after 7 weeks of pregnancy
Oct 17, 2024
Opinion
"I just had this reverence for the court. I don't anymore," says Lawrence Gostin, JD
Oct 16, 2024
Adding inavolisib to palbociclib/fulvestrant more than doubled PFS in endocrine-resistant disease
Oct 10, 2024
Conservative majority is "buying into" anti-science attitudes, warns Lawrence Gostin, JD
Oct 09, 2024
Opinion
I anticipate benefits outweighing potential risks in only a select few situations
Oct 06, 2024